Lipoplatin (Liposomal cisplatin) is a nanoparticle of 110 nm average diameter composed of lipids and cisplatin. This new drug has successfully finished Phase I, Phase II and Phase III human clinical trials.
It has shown superiority to cisplatin in combination with paclitaxel as a chemotherapy regimen in non-small cell lung cancer (NSCLC) adenocarcinomas.
|Scientific name: ||Liposomal Cisplatin|
|Commercial name(s): |
- Lipoplatin™ (for pancreatic cancer)
- Nanoplatin™ (for lung cancer)
50ml Vial: 3 mg/ml sterile nanoparticle suspension for i.v. injection.